Results 171 to 180 of about 1,329,071 (310)

Issues in the promotion and retention of urban students : report of a USI working group.

, 1998
"November, 1998."; Includes bibliographical references.Introduction -- Promotion/retention policy A -- Promotion/retention policy B -- Promotion/retention rationale ...
Urban Schools Initiative (Ohio)
core  

Prediction of cognitive outcome and progression to dementia using ω6-PUFA/ω3-PUFA ratio. [PDF]

Alzheimers Dement
Andrade V, Kleineidam L, Wagner-Thelen H, Ballarini T, Campos-Martin R, Martino-Adami P, Tripathi KP, Guyonnet S, Vellas B, Scherer M, Maier W, Pentzek M, Schmid M, Riedel-Heller S, Weyerer S, Bickel H, Wiese B, Egert S, Wagner M, Ramírez A.   +19 more
europepmc   +1 more source

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

Molecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen, Kristiane Søreng, Chiara Veroni, Laura Trachsel‐Moncho, Nagham Asp, Robin Gaupset, Lars Gustav Lyckander, Helene Knævelsrud, Lars Eftang, Anne Simonsen   +9 more
wiley   +1 more source

Advancing Evidence-Based Practice Through Social Movement Strategies: A Case Study in Healthcare Transformation. [PDF]

Healthcare (Basel)
Abalos E, Guino-O T, Lim-Saco F, Café MR, Bustillo TJ, Caluscusan K, Belciña MT, Bustamante V, Locsin R.   +8 more
europepmc   +1 more source

Russian initiative initiatives (Initiative, Enterprising, Smecticism)

, 2017
S.S. Neustroev, V.A. Predybailo, A.I. Galkina, E.A. Burnasheva, I.A. Grishan   +4 more
openaire   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Making the invisible visible: a case study of the healing hearts initiative within the SEED wellbeing program in Australian healthcare. [PDF]

Front Psychol
Pai P, Knezevic A, McCreadie D, Tanaka J, Andrade A, Wright K.   +5 more
europepmc   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

The final frontier: can Kerala lay out a roadmap to a 'zero snakebite deaths initiative' for India? [PDF]

Trop Med Health
Menon JC, Jaya AM, Sivanandan H, Suresh A, Aravind MS, Anvar M, Khobragade RN.   +6 more
europepmc   +1 more source

Rite of initiation [PDF]

Nature Structural & Molecular Biology, 1997
openaire   +2 more sources